Moore. 1998. AMD3100, a small molecule inhibitor of HIV-1 entry via the
CXCR4 co-receptor. Nat. Med. 4:72–77.
Edinger, A. L., J. L. Mankowski, B. J. Doranz, B. J. Margulies, B. Lee, J.
Rucker, M. Sharron, T. L. Hoffman, J. F. Berson, M. C. Zink, V. M. Hirsch,
J. E. Clements, and R. W. Doms. 1997. CD4-independent, CCR5-dependent
infection of brain capillary endothelial cells by a neurovirulent simian im-munodeficiency virus strain. Proc. Natl. Acad. Sci. USA 94:14742–14747.
Esko, J. D., and U. Lindahl. 2001. Molecular diversity of heparan sulfate.
J. Clin. Investig. 108:169–173.
Fiala, M., D. J. Looney, M. Stins, D. D. Way, L. Zhang, X. Gan, F. Chiappelli, E. S. Schweitzer, P. Shapshak, M. Weinand, M. C. Graves, M. Witte,
and K. S. Kim. 1997. TNF-alpha opens a paracellular route for HIV-1
invasion across the blood-brain barrier. Mol. Med. 3:553–564.
Floris, S., J. van den Born, S. M. van der Pol, C. D. Dijkstra, and H. E. De
Vries. 2003. Heparan sulfate proteoglycans modulate monocyte migration
across cerebral endothelium. J. Neuropathol. Exp. Neurol. 62:780–790.
Fortin, J. F., R. Cantin, G. Lamontagne, and M. Tremblay. 1997. Hostderived ICAM-1 glycoproteins incorporated on human immunodeficiency
virus type 1 are biologically active and enhance viral infectivity. J. Virol.
71:3588–3596.
Fortin, J. F., R. Cantin, and M. J. Tremblay. 1998. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J. Virol. 72:
2105–2112.
Fuki, I. V., M. E. Meyer, and K. J. Williams. 2000. Transmembrane and
cytoplasmic domains of syndecan mediate a multi-step endocytic pathway
involving detergent-insoluble membrane rafts. Biochem. J. 351:607–612.
Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van
Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani,
D. R. Littman, C. G. Figdor, and Y. van Kooyk. 2000. DC-SIGN, a dendritic
cell-specific HIV-1-binding protein that enhances trans-infection of T cells.
Cell 100:587–597.
Ghorpade, A., M. E. Xia, B. T. Hyman, Y. Persidsky, A. Nukuna, P. Bock, M.
Che, J. Limoges, H. E. Gendelman, and C. R. Mackay. 1998. Role of the
-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus
type 1 infection of monocytes and microglia. J. Virol. 72:3351–3361.
Gorry, P. R., G. Bristol, J. A. Zack, K. Ritola, R. Swanstrom, C. J. Birch,
J. E. Bell, N. Bannert, K. Crawford, H. Wang, D. Schols, E. De Clercq, K.
Kunstman, S. M. Wolinsky, and D. Gabuzda. 2001. Macrophage tropism of
human immunodeficiency virus type 1 isolates from brain and lymphoid
tissues predicts neurotropism independent of coreceptor specificity. J. Virol.
75:10073–10089.
Guibinga, G. H., A. Miyanohara, J. D. Esko, and T. Friedmann. 2002. Cell
surface heparan sulfate is a receptor for attachment of envelope protein-free
retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus
vectors to target cells. Mol. Ther. 5:538–546.
Harouse, J. M., S. Bhat, S. L. Spitalnik, M. Laughlin, K. Stefano, D. H.
Silberberg, and F. Gonzalez-Scarano. 1991. Inhibition of entry of HIV-1 in
neural cell lines by antibodies against galactosyl ceramide. Science 253:320–
323.
Harouse, J. M., R. G. Collman, and F. Gonzalez-Scarano. 1995. Human
immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120
involved in entry into a CD4-negative, galactosyl ceramide/3 sulfo-galactosyl
ceramide-positive cell line. J. Virol. 69:7383–7390.
He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Buscigilo, X.
Yang, W. Hofmann, W. Newman, C. R. MacKay, J. Sodroski, and D.
Gabuzda. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of
microglia. Nature 385:645–649.
Hibbitts, S., J. D. Reeves, G. Simmons, P. W. Gray, L. G. Epstein, D. Schols,
E. De Clercq, T. N. C. Wells, A. E. I. Proudfoot, and P. R. Clapham. 1999.
Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1. AIDS
Res. Hum. Retrovir. 15:989–1000.
Ibrahim, J., P. Griffin, D. R. Coombe, C. C. Rider, and W. James. 1999.
Cell-surface heparan sulfate facilitates human immunodeficiency virus type 1
entry into some cell lines but not primary lymphocytes. Virus Res. 60:159–
169.
Kim, C. W., O. A. Goldberger, R. L. Gallo, and M. Bernfield. 1994. Members
of the syndecan family of heparan sulfate proteoglycans are expressed in
distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell
5:797–805.
Kim, T. A., H. K. Avraham, Y. H. Koh, S. Jiang, I. W. Park, and S. Avraham.
2003. HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J. Immunol. 170:2629–2637.
Kolson, D. L., and R. J. Pomerantz. 1996. AIDS dementia and HIV-1-induced neurotoxicity: possible pathogenic associations and mechanisms.
J. Biomed. Sci. 3:389–414.
Krause, D., U. Mischeck, H. J. Galla, and R. Dermietzel. 1991. Correlation
of zonula occludens ZO-1 antigen expression and transendothelial resistance
in porcine and rat cultured cerebral endothelial cells. Neurosci. Lett. 128:
301–304.
Lanzavecchia, A. 1996. Mechanisms of antigen uptake for presentation.
Curr. Opin. Immunol. 8:348–354.
